7.17
price up icon0.14%   0.010
 
loading

Mimedx Group Inc Azioni (MDXG) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
11.79%
98.61
88.20 92.91 84.06 87.21
Cost Of Revenue
12.82%
18.68
16.56 16.91 15.32 14.86
Gross Profit
11.55%
79.92
71.65 76.00 68.73 72.35
Operating Expenses
6.56%
67.55
63.40 64.94 57.57 48.90
Benefits Costs and Expenses
7.54%
85.60
79.59 81.66 72.64 63.99
Costs And Expenses
7.54%
85.60
79.59 81.66 72.64 63.99
Operating Income/Loss
49.92%
12.37
8.251 11.05 11.16 23.45
Income/Loss From Continuing Operations Before Tax
51.03%
13.01
8.612 11.25 11.42 23.22
Income Tax Expense/Benefit
113.28%
3.389
1.589 3.811 3.541 5.595
Income/Loss From Continuing Operations After Tax
36.95%
9.618
7.023 7.438 7.878 17.62
Income/Loss From Discontinued Operations, Net Of Tax
-
- - 0.217 0.004
Net Income/Loss
36.95%
9.618
7.023 7.438 8.095 17.62
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.33%
147.76
147.27 -0.0294 146.96 147.33
Diluted Average Shares
0.24%
149.32
149.68 0.0844 148.37 148.90
Basic Earnings Per Share
40.00%
0.07
0.05 0.05 0.05 0.12
Diluted Earnings Per Share
20.00%
0.06
0.05 0.05 0.05 0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):